DOI · e01.org

Chimeric Antigen Receptor Therapy for B-cell Malignancies

David L. Porter, Michael D. Kalos, Zhaohui Zheng, Bruce L. Levine, Carl H. June · Journal of Cancer · 2011

  • DOI 10.7150/jca.2.331
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2011

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2011

Abstract

We presented data showing that the CART-19 cells expressing the 4-1BB signaling domain can have unprecedented and massive in-vivo expansion, traffic to tumor sites, persist long term in vivo, and induce rapid and potent anti-tumor activity in chemotherapy refractory CLL patients.

Open the resolved locator · 10.7150/jca.2.331

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 19:55 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v02p0331.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.